CD274 and lung carcinoma: Leveraging this integrated TSA-IF-FISH platform, we aim to characterize PD-L1+ CTCs, CTECs, and WBC subpopulations and assess their clinical relevance in advanced lung cancer patients undergoing immunotherapy.